CytomX Therapeutics (CTMX) Tax Provisions (2015 - 2026)
CytomX Therapeutics (CTMX) posted Tax Provisions of $59000.0 for Q1 2026, up 101.56% on a QoQ basis from -$3.8 million in Q4 2025, and down 4.84% year-over-year from $62000.0 in Q1 2025.
CytomX Therapeutics (CTMX) Tax Provisions (2015 - 2026) Analysis & Trends
CytomX Therapeutics' Tax Provisions history runs 10 years deep, the most recent figure standing at $59000.0 for Q1 2026.
- Quarterly Tax Provisions fell 4.84% year-over-year to $59000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.6 million (down 1626.27% YoY) and the FY2025 annual result came in at -$3.6 million, down 1706.25% from the prior year.
- Tax Provisions was $59000.0 for Q1 2026 at CytomX Therapeutics, up from -$3.8 million in the prior quarter.
- Across five years, Tax Provisions topped out at $2.8 million in Q3 2023 and bottomed at -$3.8 million in Q4 2025.
- A 4-year average of $52272.7 and a median of $61000.0 in 2024 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 26.53% in 2025, while the deepest fall reached 6200.0% in 2025.
- CytomX Therapeutics' Tax Provisions stood at $1.1 million in 2023, then tumbled by 94.2% to $62000.0 in 2024, then tumbled by 6200.0% to -$3.8 million in 2025, then soared by 101.56% to $59000.0 in 2026.
- Business Quant data shows CTMX's Tax Provisions at $59000.0 in Q1 2026, -$3.8 million in Q4 2025, and $58000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | CytomX Therapeutics | 574.36 Mn | 227.66 Mn | - | 59,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59,000.00 |
| Dec 31, 2025 | -3.78 Mn |
| Sep 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Mar 31, 2025 | 62,000.00 |
| Dec 31, 2024 | 62,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Jun 30, 2024 | 51,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Dec 31, 2023 | 1.07 Mn |
| Sep 30, 2023 | 2.82 Mn |
| Dec 31, 2020 | 11,000.00 |
| Mar 31, 2020 | -13.91 Mn |
| Dec 31, 2019 | -384,000.00 |
| Mar 31, 2019 | -6,000.00 |
| Dec 31, 2018 | 8.91 Mn |
| Sep 30, 2018 | 2.50 Mn |
| Jun 30, 2018 | 1.79 Mn |
| Mar 31, 2018 | 1.10 Mn |
| Dec 31, 2017 | -520,000.00 |